ADAPY — ADAPTIMMUNE THERAPEUTICS PLC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $65.1M | -54.0% | -$169.8M | — | — | — | -221.8% | — | — | — | — |
Revenue YoY trend Net margin trend
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
ADAPY (ADAPTIMMUNE THERAPEUTICS PLC) is tracked on HoldingsHub across five years of quarterly 13F filings. 149 funds have reported positions historically, with the sum of their latest reported stakes valued at $109.45M. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
Major shareholders of ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) include Matrix Capital Management Company, LP, Capital World Investors, EcoR1 Capital, LLC, ranked by reported 13F value among the 149 institutional holders on this page.
ADAPY is classified in the Materials sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q1 2026 | 1 | 3.66K | $72 | +0.0% |
| Q4 2025 | 8 | 1.63M | $79.72K | +18.8% |
| Q3 2025 | 55 | 40.76M | $5.30M | +9.3% |
| Q2 2025 | 62 | 108.79M | $26.07M | -0.3% |
| Q1 2025 | 64 | 108.62M | $21.40M | +9.2% |
| Q4 2024 | 76 | 118.21M | $63.68M | -4.8% |
| Q3 2024 | 76 | 146.66M | $139.36M | +1.6% |
| Q2 2024 | 69 | 148.54M | $144.81M | -4.5% |
Over the 8 quarters shown, institutional share counts decreased 100% in aggregate (Q2 2024 → Q1 2026); the largest single-quarter swing was Q4 2025 (+18.8%).
Top Institutional Holders (Q1 2026) — 1 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.66K | $72 | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q4 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 20.00K | $37.80K | 0.03% | New | |
| 800.00K | $20.80K | 0.00% | Hold | |
| 432.82K | $11.25K | 0.00% | Hold | |
| 353.84K | $9.20K | 0.00% | Add | |
| 18.61K | $483 | 0.00% | Add | |
| 3.66K | $95 | 0.00% | Reduce | |
| 2.53K | $66 | 0.00% | Hold | |
| 907 | $23 | 0.00% | Hold |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 18.58M | $2.42M | 0.12% | Reduce | |
| 6.67M | $866.76K | 0.00% | Add | |
| 4.05M | $527.03K | 0.00% | Add | |
| 3.67M | $476.59K | 0.00% | Reduce | |
| 2.81M | $364.69K | 0.00% | New | |
| 1.32M | $171.56K | 0.00% | Add | |
| 800.00K | $104.00K | 0.01% | Hold | |
| 500.00K | $65.00K | 0.00% | New | |
| 432.82K | $56.27K | 0.00% | Hold | |
| 340.41K | $44.25K | 0.00% | Reduce | |
| 308.06K | $40.05K | 0.00% | Add | |
| 137.70K | $17.90K | 0.00% | New | |
| 114.26K | $14.85K | 0.01% | New | |
| 110.40K | $14.35K | 0.01% | New | |
| 102.50K | $13.32K | 0.00% | Add | |
| 73.38K | $9.54K | 0.00% | Hold | |
| 68.72K | $8.93K | 0.00% | Reduce | |
| 67.03K | $8.71K | 0.00% | Hold | |
| 61.73K | $8.03K | 0.00% | New | |
| 54.82K | $7.13K | 0.00% | Hold | |
| 54.72K | $7.11K | 0.00% | Hold | |
| 53.19K | $6.91K | 0.00% | Hold | |
| 48.58K | $6.32K | 0.00% | Reduce | |
| 40.82K | $5.66K | 0.00% | Add | |
| 38.30K | $4.98K | 0.00% | Reduce |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 27.40M | $6.57M | 0.40% | Hold | |
| 23.76M | $5.69M | 0.28% | Hold | |
| 22.58M | $5.41M | 0.10% | Add | |
| 17.08M | $4.09M | 0.31% | Hold | |
| 4.41M | $1.06M | 0.18% | Reduce | |
| 4.23M | $1.01M | 0.00% | Add | |
| 2.48M | $595.29K | 0.04% | Hold | |
| 1.88M | $451.32K | 0.00% | Add | |
| 1.14M | $272.87K | 0.00% | Hold | |
| 800.00K | $191.76K | 0.01% | New | |
| 464.28K | $111.29K | 0.00% | Reduce | |
| 432.82K | $103.75K | 0.00% | Hold | |
| 426.71K | $102.28K | 0.00% | Add | |
| 179.09K | $42.93K | 0.00% | Reduce | |
| 175.56K | $42.08K | 0.02% | Add | |
| 145.40K | $34.85K | 0.00% | Reduce | |
| 109.05K | $26.14K | 0.01% | New | |
| 90.06K | $20.71K | 0.00% | Add | |
| 80.02K | $19.18K | 0.00% | New | |
| 79.08K | $18.96K | 0.00% | Reduce | |
| 73.38K | $17.59K | 0.00% | Hold | |
| 67.03K | $16.07K | 0.00% | Reduce | |
| 62.96K | $15.11K | 0.00% | Reduce | |
| 54.82K | $13.14K | 0.00% | Hold | |
| 54.72K | $13.12K | 0.00% | Hold |
Q1 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 27.40M | $5.40M | 0.33% | Hold | |
| 23.76M | $4.68M | 0.20% | Add | |
| 20.53M | $4.04M | 0.14% | Add | |
| 17.08M | $3.36M | 0.26% | Hold | |
| 4.89M | $964.19K | 0.17% | Reduce | |
| 2.72M | $535.04K | 0.00% | Add | |
| 2.48M | $489.24K | 0.03% | Hold | |
| 1.81M | $357.33K | 0.00% | Reduce | |
| 1.75M | $345.71K | 0.00% | Reduce | |
| 1.15M | $225.96K | 0.00% | Reduce | |
| 1.01M | $199.51K | 0.00% | Add | |
| 882.33K | $173.82K | 0.00% | Reduce | |
| 432.82K | $85.27K | 0.00% | Hold | |
| 421.29K | $83.00K | 0.00% | Add | |
| 240.72K | $47.42K | 0.00% | Add | |
| 206.73K | $40.73K | 0.00% | Add | |
| 183.69K | $36.19K | 0.00% | Hold | |
| 150.15K | $29.58K | 0.01% | Reduce | |
| 135.95K | $26.78K | 0.00% | Add | |
| 109.07K | $21.49K | 0.00% | Reduce | |
| 94.28K | $18.57K | 0.00% | Add | |
| 94.28K | $18.57K | 0.00% | Add | |
| 87.27K | $17.19K | 0.00% | Add | |
| 80.61K | $15.88K | 0.00% | Reduce | |
| 78.03K | $15.37K | 0.00% | Add |
Q4 2024 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 27.40M | $14.76M | 0.58% | Hold | |
| 20.49M | $11.04M | 0.56% | Add | |
| 17.08M | $9.20M | 0.52% | Hold | |
| 14.84M | $7.99M | 0.82% | New | |
| 11.82M | $6.37M | 0.01% | Reduce | |
| 5.10M | $2.75M | 0.39% | Hold | |
| 4.87M | $2.62M | 0.19% | Reduce | |
| 2.86M | $1.54M | 0.00% | Reduce | |
| 2.53M | $1.36M | 0.00% | Add | |
| 2.48M | $1.34M | 0.05% | Add | |
| 1.76M | $950.54K | 0.00% | Add | |
| 1.32M | $713.71K | 0.00% | Reduce | |
| 916.94K | $493.96K | 0.00% | Reduce | |
| 715.61K | $385.50K | 0.03% | Hold | |
| 529.12K | $285.73K | 0.00% | Add | |
| 432.82K | $233.16K | 0.00% | Hold | |
| 400.08K | $215.52K | 0.00% | Add | |
| 326.94K | $176.12K | 0.00% | Add | |
| 255.36K | $137.56K | 0.06% | Hold | |
| 183.69K | $98.95K | 0.00% | Reduce | |
| 183.48K | $98.84K | 0.00% | Add | |
| 141.74K | $76.40K | 0.00% | Add | |
| 139.80K | $75.31K | 0.00% | Hold | |
| 122.70K | $66.00K | 0.00% | Add | |
| 83.20K | $44.00K | 0.00% | New |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RHUMBLINE ADVISERS | 3.66K | 3.66K | 5.74K | 8.53K | 18.31K | 19.75K | 19.16K | 16.72K | 7.12K | 5.91K | 5.58K | — | — | — | — | — | — | — | — | — |
| Matrix Capital Management Company, LP | — | — | — | — | — | — | 37.68M | 38.97M | 38.97M | 38.97M | 38.97M | — | — | — | — | — | — | — | — | — |
| EcoR1 Capital, LLC | — | — | — | 27.40M | 27.40M | 27.40M | 27.40M | 27.40M | 27.40M | — | — | — | — | — | — | — | — | — | — | — |
| NEA Management Company, LLC | — | — | — | 17.08M | 17.08M | 17.08M | 17.08M | 17.08M | 17.08M | 17.08M | 17.08M | — | — | — | — | — | — | — | — | — |
| Baillie Gifford & Co | — | — | — | — | — | 11.82M | 16.78M | 15.15M | 15.87M | 15.91M | 17.15M | 17.18M | 17.11M | 17.17M | 14.66M | 15.32M | 15.38M | 13.76M | 12.82M | 11.70M |
| BAKER BROS. ADVISORS LP | — | — | — | — | — | — | — | 2.34M | 10.79M | 10.97M | 10.97M | — | — | — | — | — | — | — | — | — |
| Long Focus Capital Management, LLC | — | — | 18.58M | 23.76M | 23.76M | 20.49M | 13.30M | 12.35M | 10.68M | 12.09M | 10.96M | — | — | — | — | — | — | — | — | — |
| PFM Health Sciences, LP | — | — | — | — | — | 4.87M | 10.00M | 10.52M | 10.42M | 10.42M | 10.42M | — | — | — | — | — | — | — | — | — |
| Point72 Asset Management | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 647.01K | 582.51K | 565.21K | 76.30K | 2.06M |
| MPM BioImpact LLC | — | — | — | 4.41M | 4.89M | 5.10M | 5.10M | 5.10M | 5.10M | 5.10M | 5.10M | — | — | — | — | — | — | — | — | — |
| Two Seas Capital LP | — | — | — | 22.58M | 20.53M | 14.84M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Bank of America Corp | — | — | 1.32M | 1.14M | 1.15M | 2.86M | 4.65M | 4.65M | 4.67M | 4.70M | 4.70M | 4.70M | 5.40M | 4.74M | 1.04M | 991.44K | 524.21K | 538.11K | 732.10K | — |
| TANG CAPITAL MANAGEMENT LLC | — | — | — | — | — | — | — | 1.74M | 1.44M | 4.39M | 5.17M | — | — | — | — | — | — | — | — | — |
| Rock Springs Capital Management LP | — | — | — | 2.48M | 2.48M | 2.48M | 2.43M | 2.43M | 2.43M | 2.43M | 2.79M | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | — | — | 340.41K | 464.28K | 1.75M | 1.76M | 1.74M | 1.69M | 1.73M | 1.73M | 1.73M | 1.73M | 1.58M | 1.58M | 1.58M | 1.58M | 1.58M | 1.58M | 1.58M | — |
| Citadel Advisors | — | — | 137.70K | — | 14.20K | 14.70K | 5.80K | 13.40K | 28.50K | 3.40M | 400 | 3.38M | 1.14M | 256.34K | 1.56M | 1.56M | 1.79M | 1.58M | 2.76M | — |
| Renaissance Technologies | — | — | 4.05M | 1.88M | 1.81M | 2.53M | 1.66M | 1.79M | 1.39M | 1.37M | 1.03M | 1.51M | 182.70K | 560.97K | 566.23K | 510.00K | 959.70K | 427.69K | — | 303.50K |
| Morgan Stanley | — | — | 3.67M | 4.23M | 2.72M | 1.32M | 1.70M | 440.83K | 373.28K | 1.96M | 2.05M | 2.08M | 2.25M | 2.29M | 2.27M | 2.08M | 2.05M | 2.24M | 334.97K | — |
| JPMorgan Chase & Co | — | — | — | 22.78K | 882.33K | 916.94K | 1.05M | 1.04M | 915.03K | 928.22K | 1.03M | 1.30M | 1.30M | 1.00M | 1.01M | 1.47M | 1.40M | 1.48M | 1.60M | — |
| MILLENNIUM MANAGEMENT LLC | — | — | — | — | 94.28K | 29.56K | 715.35K | 779.62K | 825.18K | 441.03K | 300.06K | — | — | — | — | — | — | — | — | — |
FAQ
Which funds hold ADAPY?
149 funds have reported positions in ADAPY across five years of 13F filings; the sum of their latest reported stakes is $109.45M.
Who are the top institutional holders of ADAPY?
The largest 13F holders are Matrix Capital Management Company, LP, Capital World Investors, EcoR1 Capital, LLC, Baillie Gifford & Co, Two Seas Capital LP; the top 25 are ranked at the top of this page.
Who are the major shareholders of ADAPTIMMUNE THERAPEUTICS PLC?
The major shareholders of ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) by reported 13F value are Matrix Capital Management Company, LP, Capital World Investors, EcoR1 Capital, LLC, Baillie Gifford & Co, Two Seas Capital LP, among 149 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.